Cuprina Holdings is trading at $1.60, down 7.46%, after closing a $4.97 million public offering on September 17, 2026, creating dilution.
- Issued 4,322,489 Class A ordinary shares at $1.15 each, below the September 17 close of $1.73; the underwriter also received a 45-day option for up to 648,373 additional shares.
- The financing supports biomedical expansion, but dilution is pressuring shares.
- Bitcoin and Ethereum are rising, so crypto-market weakness does not explain the decline.